How BPC-157 Peptide Is Administered BPC-157 can theoretically be delivered several ways, but in a medical clinic like ours, the clinically relevant routes are two: subcutaneous injection and, in selected cases, oral capsules for gut-specific indications
Think about it, he said
The bodily introduction into humans or animals is strictly prohibited by law
Stronger regulatory frameworks are needed to ensure safety and efficacy
Active at nanomolar concentrations: Unlike many peptides that require high systemic concentrations, GHK-Cu has been shown to exert meaningful biological effects at nanomolar (10 M) concentrations making it effective even at low doses
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1